Cardinal Health, Inc. (NYSE:CAH) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 26.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 85,724 shares of the company's stock after buying an additional 17,971 shares during the quarter. Quantinno Capital Management LP's holdings in Cardinal Health were worth $9,474,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. CWM LLC lifted its position in shares of Cardinal Health by 2.8% during the second quarter. CWM LLC now owns 12,500 shares of the company's stock worth $1,229,000 after purchasing an additional 345 shares in the last quarter. Opal Wealth Advisors LLC purchased a new position in Cardinal Health in the 2nd quarter valued at approximately $135,000. Gateway Investment Advisers LLC grew its stake in shares of Cardinal Health by 16.2% in the second quarter. Gateway Investment Advisers LLC now owns 5,565 shares of the company's stock worth $547,000 after acquiring an additional 774 shares in the last quarter. Peak Financial Advisors LLC increased its position in shares of Cardinal Health by 9.4% during the second quarter. Peak Financial Advisors LLC now owns 27,370 shares of the company's stock worth $2,691,000 after acquiring an additional 2,343 shares during the period. Finally, Mirador Capital Partners LP raised its stake in shares of Cardinal Health by 5.0% in the second quarter. Mirador Capital Partners LP now owns 12,451 shares of the company's stock valued at $1,224,000 after acquiring an additional 597 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Down 0.1 %

Shares of NYSE CAH traded down $0.06 during trading hours on Friday, reaching $122.78. The stock had a trading volume of 1,583,878 shares, compared to its average volume of 2,103,709. The firm has a market cap of $29.71 billion, a price-to-earnings ratio of 23.90, a PEG ratio of 1.54 and a beta of 0.61. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $126.23. The firm has a 50-day moving average of $116.03 and a 200-day moving average of $107.39.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The business had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company's revenue was down 4.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.73 earnings per share. On average, equities analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a $0.5056 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.65%. Cardinal Health's dividend payout ratio is presently 39.30%.

Analyst Ratings Changes

Several research firms recently commented on CAH. Barclays boosted their target price on Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research note on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 21st. StockNews.com downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd. Evercore ISI increased their price objective on shares of Cardinal Health from $105.00 to $115.00 and gave the company an "in-line" rating in a research report on Thursday, August 15th. Finally, Argus lifted their price objective on shares of Cardinal Health from $115.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, September 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $124.58.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.